Skip Navigation

Publication Detail

Title: Impaired Alveolar Re-Epithelialization in Pulmonary Emphysema.

Authors: Lin, Chih-Ru; Bahmed, Karim; Kosmider, Beata

Published In Cells, (2022 Jun 28)

Abstract: Alveolar type II (ATII) cells are progenitors in alveoli and can repair the alveolar epithelium after injury. They are intertwined with the microenvironment for alveolar epithelial cell homeostasis and re-epithelialization. A variety of ATII cell niches, transcription factors, mediators, and signaling pathways constitute a specific environment to regulate ATII cell function. Particularly, WNT/β-catenin, YAP/TAZ, NOTCH, TGF-β, and P53 signaling pathways are dynamically involved in ATII cell proliferation and differentiation, although there are still plenty of unknowns regarding the mechanism. However, an imbalance of alveolar cell death and proliferation was observed in patients with pulmonary emphysema, contributing to alveolar wall destruction and impaired gas exchange. Cigarette smoking causes oxidative stress and is the primary cause of this disease development. Aberrant inflammatory and oxidative stress responses result in loss of cell homeostasis and ATII cell dysfunction in emphysema. Here, we discuss the current understanding of alveolar re-epithelialization and altered reparative responses in the pathophysiology of this disease. Current therapeutics and emerging treatments, including cell therapies in clinical trials, are addressed as well.

PubMed ID: 35805139 Exiting the NIEHS site

MeSH Terms: Alveolar Epithelial Cells/metabolism; Humans; Lung/metabolism; Pulmonary Alveoli/metabolism; Pulmonary Emphysema*/etiology; Pulmonary Emphysema*/metabolism; Re-Epithelialization

Back
to Top